Investor Overview

VYNE Therapeutics™ is a biopharmaceutical company.

Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.

NASDAQ-GS: VYNE

0.22

Oct. 01, 2022 19:26:36
  • Change -0.0121 (-5.144556%)
  • Volume 101,037
  • Today's Open 0.2423
  • Previous Close 0.2352
  • Today's High 0.245
  • Today's Low 0.2231
  • 52 Week High 1.75
  • 52 Week Low 0.221